SCHEMBL4584257

SCHEMBL4584257

COc1ccc(C=CS(=O)(=O)CS(=O)(=O)/C=C/c2ccc(O)c(OC)c2)cc1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 5/20 0.64
MAPT P10636 2/20 0.64
TUBB1 Q9H4B7 6/20 0.62
ABCB1 P08183 2/20 0.57
TUBB4A P04350 2/20 0.57
TUBB P07437 2/20 0.57
TUBA3C P0DPH7 2/20 0.57
TUBA1B P68363 2/20 0.57
TUBA4A P68366 2/20 0.57
TUBB4B P68371 2/20 0.57
TUBB3 Q13509 2/20 0.57
TUBB2A Q13885 2/20 0.57
TUBB8 Q3ZCM7 2/20 0.57
TUBA3E Q6PEY2 2/20 0.57
TUBA1A Q71U36 2/20 0.57
TUBA1C Q9BQE3 2/20 0.57
TUBB6 Q9BUF5 2/20 0.57
TUBB2B Q9BVA1 2/20 0.57
SLC22A2 O15244 1/20 0.57
SLCO2B1 O94956 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4584256 1.00 APP (0.64) APPMAPTTUBB1ABCB1TUBB4A
SCHEMBL4584259 1.00 APP (0.64) APPMAPTTUBB1ABCB1TUBB4A
SCHEMBL1323553 0.94 TTR (0.62) APPMAPTABCB1TTRALOX5
SCHEMBL1323574 0.94 TUBB1 (0.65) APPMAPTTUBB1ABCB1TUBB4A
SCHEMBL1323551 0.94 TTR (0.62) APPMAPTABCB1TTRALOX5
SCHEMBL1323569 0.94 TUBB1 (0.65) APPMAPTTUBB1ABCB1TUBB4A
SCHEMBL1323549 0.94 TTR (0.62) APPMAPTABCB1TTRALOX5
SCHEMBL1323565 0.94 TUBB1 (0.65) APPMAPTTUBB1ABCB1TUBB4A
SCHEMBL1324322 0.94 TTR (0.62) APPMAPTABCB1TTRALOX5
SCHEMBL1323567 0.94 TUBB1 (0.65) APPMAPTTUBB1ABCB1TUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080070974-A1 Alpha, Beta-Unsaturated Sulfones, Sulfoxides, Sulfonimides, Sulfinimides, Acylsulfonamides and Acylsulfinamides and Therapeutic Uses Thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080070974-A1 Alpha, Beta-Unsaturated Sulfones, Sulfoxides, Sulfonimides, Sulfinimides, Acylsulfonamides and Acylsulfinamides and Therapeutic Uses Thereof DEGS1, SULT1E1, PTDSS1 APP 121/4885MAPT 1790/4885TUBB1 575/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.